{
    "ticker": "STEL",
    "name": "Stellar Biotechnologies, Inc.",
    "description": "Stellar Biotechnologies, Inc. is a biotechnology company focused on developing and commercializing innovative biological products derived from the ocean. Founded in 2011, Stellar is known for its proprietary technologies in the field of immunotherapy and vaccine development. The company specializes in producing key components for therapeutic proteins, specifically those sourced from marine organisms, which are essential for advancing treatment options in various diseases. Stellar's flagship product, KLH (Keyhole Limpet Hemocyanin), is a potent immunological adjuvant that enhances the effectiveness of vaccines and is utilized in clinical research and therapeutic applications. Stellar is committed to sustainable practices, ensuring that its sourcing of marine materials is environmentally responsible and adheres to strict regulations. Its ongoing research efforts aim to expand the applications of KLH in immunotherapy for cancer and other immune-related conditions. With a dedicated team of scientists and industry experts, Stellar Biotechnologies is positioned to make significant contributions to the fields of biotechnology and pharmaceuticals.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Port Hueneme, California, USA",
    "founded": "2011",
    "website": "https://www.stellarbiotechnologies.com",
    "ceo": "Cynthia K. B. M. M. W. G. S. McCulloch",
    "social_media": {
        "twitter": "https://twitter.com/StellarBio",
        "linkedin": "https://www.linkedin.com/company/stellar-biotechnologies-inc/"
    },
    "investor_relations": "https://www.stellarbiotechnologies.com/investor-relations",
    "key_executives": [
        {
            "name": "Cynthia K. B. M. M. W. G. S. McCulloch",
            "position": "CEO"
        },
        {
            "name": "David E. D. H. M. McCulloch",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Biological Products",
            "products": [
                "KLH (Keyhole Limpet Hemocyanin)"
            ]
        }
    ],
    "seo": {
        "meta_title": "Stellar Biotechnologies, Inc. | Innovative Biological Products",
        "meta_description": "Explore Stellar Biotechnologies, Inc., a leader in biotechnology focused on marine-derived biological products. Learn about KLH and its applications in immunotherapy.",
        "keywords": [
            "Stellar Biotechnologies",
            "KLH",
            "Biotechnology",
            "Immunotherapy",
            "Vaccine Development"
        ]
    },
    "faq": [
        {
            "question": "What is Stellar Biotechnologies known for?",
            "answer": "Stellar Biotechnologies is known for developing innovative biological products, particularly KLH, used in immunotherapy and vaccine development."
        },
        {
            "question": "Who is the CEO of Stellar Biotechnologies?",
            "answer": "Cynthia K. B. M. M. W. G. S. McCulloch is the CEO of Stellar Biotechnologies, Inc."
        },
        {
            "question": "Where is Stellar Biotechnologies headquartered?",
            "answer": "Stellar Biotechnologies is headquartered in Port Hueneme, California, USA."
        },
        {
            "question": "What are Stellar's main products?",
            "answer": "Stellar's main product is KLH (Keyhole Limpet Hemocyanin), a powerful immunological adjuvant."
        },
        {
            "question": "When was Stellar Biotechnologies founded?",
            "answer": "Stellar Biotechnologies was founded in 2011."
        }
    ],
    "competitors": [
        "VSTM",
        "IMMP",
        "CBAY"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "REGN",
        "NVAX"
    ]
}